Early versus deferred standard androgen suppression therapy for advanced hormone‐sensitive prostate cancer
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Early Versus Deferred Standard Androgen Suppression Therapy for Advanced Hormone‐sensitive Prostate Cancer." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/438611/all/images/ios-appstore-badge.png. Accessed 28 April 2024.
Early versus deferred standard androgen suppression therapy for advanced hormone‐sensitive prostate cancer. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/438611/all/images/ios-appstore-badge.png. Accessed April 28, 2024.
Early versus deferred standard androgen suppression therapy for advanced hormone‐sensitive prostate cancer. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/438611/all/images/ios-appstore-badge.png
Early Versus Deferred Standard Androgen Suppression Therapy for Advanced Hormone‐sensitive Prostate Cancer [Internet]. In: Cochrane Abstracts. [cited 2024 April 28]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/438611/all/images/ios-appstore-badge.png.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Early versus deferred standard androgen suppression therapy for advanced hormone‐sensitive prostate cancer
ID - 438611
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/438611/all/images/ios-appstore-badge.png
DB - Evidence Central
DP - Unbound Medicine
ER -